Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus

Nagwa Mohamed Assem1, Amany Ibrahim Mohammed2, Hamed Mohamed Abdel Barry2

  • 1Department of Biochemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt.

Egyptian Liver Journal
|December 5, 2022
PubMed

Insights

Hepatitis C virus (HCV) infection can impact kidney function. Elevated cystatin C and a reduced creatinine/cystatin C ratio may signal early renal dysfunction in HCV patients, even with normal creatinine levels.

Area of Science:

  • Nephrology
  • Hepatology
  • Clinical Biomarkers

Background:

  • Hepatitis C virus (HCV) infection is associated with extrahepatic manifestations, including renal dysfunction.
  • Early detection of renal affection in HCV patients is crucial for timely intervention.
  • Biomarkers like cystatin C, cryoglobulins, rheumatoid factor (RF), and complement C3 are investigated for their diagnostic role.

Purpose of the Study:

  • To evaluate the diagnostic utility of cystatin C, cryoglobulins, RF, and complement C3 in identifying renal dysfunction in newly diagnosed HCV patients.
  • To assess the relationship between these biomarkers and renal function parameters in HCV infection.

Main Methods:

  • A cohort of 400 individuals screened for HCV infection was studied.
  • Participants were divided into three groups: healthy controls, HCV antibody-positive/PCR-negative, and HCV antibody-positive/PCR-positive (Group IIb).
  • Serum and urine samples were analyzed for various biochemical markers, including cystatin C, creatinine, bilirubin, albumin, and urine albumin/creatinine ratio.

Main Results:

  • HCV patients (Group IIb) exhibited elevated total bilirubin, AST, ALT, and urine albumin/creatinine ratio, with decreased serum albumin and creatinine clearance.
  • Despite normal blood urea nitrogen and serum creatinine, Group IIb showed increased cystatin C, cryoglobulins, and RF, alongside decreased serum creatinine/cystatin C ratio and complement C3 levels.
  • Significantly higher serum cystatin C (>1.24 mg/L) and lower creatinine/cystatin C ratio (<70.1 μMol/mg) were observed in HCV-infected patients, correlating with liver and kidney parameters.

Conclusions:

  • Elevated serum cystatin C and a reduced creatinine/cystatin C ratio serve as potential early indicators of mild renal dysfunction in HCV-infected individuals.
  • These biomarkers can detect renal impairment even when serum creatinine levels remain within the normal range.
  • The findings highlight the importance of monitoring cystatin C in HCV patients for early detection of kidney involvement.
Abstract

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
33
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
138
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
54
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
139
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
60
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
16